ENTRY       D12367                      Drug
NAME        Domvanalimab (USAN/INN)
FORMULA     C6422H9938N1712O2001S48
EXACT_MASS  144593.5114
MOL_WEIGHT  144683.0129
SEQUENCE    (Heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS NFGMHWVRQA PGKGLEWVAF ISSGSSSIYY
            ADTVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCARMR LDYYAMDYWG QGTMVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPEAAGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASKSIS KYLAWYQQKP GKAPKLLIYS GSTLQSGVPS
            RFSGSGSGTD 	FTLTISSLQP EDFATYYCQQ HNEYPWTFGG GTKVEIKRTV
            AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD
            STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide birdge: H22-H96, H146-H202, H222-L214, H228-H'228, H231-H'231, H263-H323, H369-H427, H'22-H'96, H'146-H'202, H'222-L'214, H'263-H'323, H'369-H'427, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
CLASS       Antineoplastic
             DG02938  Immune checkpoint inhibitor
EFFICACY    Antineoplastic, Immune checkpoint inhibitor, Anti-TIGIT antibody
  TYPE      Monoclonal antibody
TARGET      TIGIT [HSA:201633] [KO:K16350]
  PATHWAY   hsa04514(201633)  Cell adhesion molecules
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG02938  Immune checkpoint inhibitor
               D12367  Domvanalimab
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               Other
                TIGIT
                 D12367  Domvanalimab (USAN/INN)
DBLINKS     CAS: 2368219-35-4
///
